Training activity information

Details

Perform and interpret assays for the measurement of four of the following:

  • Lamotrigine
  • Levetiracetam
  • Clozapine
  • Tacrolimus
  • Ciclosporin
  • Infliximab

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

  • Local and national training guidelines, standards and pathways
  • Method selection, including pre-analytical issues, assay advantages and limitations, quality parameters, and interferences
  • Equipment calibration and maintenance
  • Quality control; EQA and IQC
  • National and international guidelines
  • Role of the duty biochemist
  • Turnaround times and impact on patient care

Relevant learning outcomes

# Outcome
# 1 Outcome

Analyse drugs, vitamins and trace elements in various biological matrices via quantitative and qualitative assays using automated and manual methodologies.

# 2 Outcome

Apply the appropriate investigative strategy to clinical situations which may involve drugs or poisons, advising clinical teams on the appropriate course of action.

# 5 Outcome

Demonstrate the application of pharmacokinetics and pharmacogenomics in therapeutic drug monitoring.

# 6 Outcome

Illustrate how toxicology results are used in clinical practice and the legal consequences of drug testing in various settings.